BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 21128598)

  • 1. OCT2 and MATE1 provide bidirectional agmatine transport.
    Winter TN; Elmquist WF; Fairbanks CA
    Mol Pharm; 2011 Feb; 8(1):133-42. PubMed ID: 21128598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of functional amino acid residues involved in polyamine and agmatine transport by human organic cation transporter 2.
    Higashi K; Imamura M; Fudo S; Uemura T; Saiki R; Hoshino T; Toida T; Kashiwagi K; Igarashi K
    PLoS One; 2014; 9(7):e102234. PubMed ID: 25019617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transport of guanidine compounds by human organic cation transporters, hOCT1 and hOCT2.
    Kimura N; Masuda S; Katsura T; Inui K
    Biochem Pharmacol; 2009 Apr; 77(8):1429-36. PubMed ID: 19426682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mitochondrial fluorescent dye rhodamine 123 is a high-affinity substrate for organic cation transporters (OCTs) 1 and 2.
    Jouan E; Le Vee M; Denizot C; Da Violante G; Fardel O
    Fundam Clin Pharmacol; 2014 Feb; 28(1):65-77. PubMed ID: 22913740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcellular transport of organic cations in double-transfected MDCK cells expressing human organic cation transporters hOCT1/hMATE1 and hOCT2/hMATE1.
    Sato T; Masuda S; Yonezawa A; Tanihara Y; Katsura T; Inui K
    Biochem Pharmacol; 2008 Oct; 76(7):894-903. PubMed ID: 18674516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transport of paraquat by human organic cation transporters and multidrug and toxic compound extrusion family.
    Chen Y; Zhang S; Sorani M; Giacomini KM
    J Pharmacol Exp Ther; 2007 Aug; 322(2):695-700. PubMed ID: 17495125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Competitive inhibition of the luminal efflux by multidrug and toxin extrusions, but not basolateral uptake by organic cation transporter 2, is the likely mechanism underlying the pharmacokinetic drug-drug interactions caused by cimetidine in the kidney.
    Ito S; Kusuhara H; Yokochi M; Toyoshima J; Inoue K; Yuasa H; Sugiyama Y
    J Pharmacol Exp Ther; 2012 Feb; 340(2):393-403. PubMed ID: 22072731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Substrate-Dependent Inhibition on Renal Organic Cation Transporters hOCT2 and hMATE1/2-K-Mediated Drug Transport and Intracellular Accumulation.
    Yin J; Duan H; Wang J
    J Pharmacol Exp Ther; 2016 Dec; 359(3):401-410. PubMed ID: 27758931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agmatine is efficiently transported by non-neuronal monoamine transporters extraneuronal monoamine transporter (EMT) and organic cation transporter 2 (OCT2).
    Gründemann D; Hahne C; Berkels R; Schömig E
    J Pharmacol Exp Ther; 2003 Feb; 304(2):810-7. PubMed ID: 12538837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of
    López Quiñones AJ; Wagner DJ; Wang J
    Mol Pharmacol; 2020 Aug; 98(2):109-119. PubMed ID: 32487736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of organic cation transporter OCT2 and multidrug and toxin extrusion proteins MATE1 and MATE2-K for transport and drug interactions of the antiviral lamivudine.
    Müller F; König J; Hoier E; Mandery K; Fromm MF
    Biochem Pharmacol; 2013 Sep; 86(6):808-15. PubMed ID: 23876341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-transfected MDCK cells expressing human OCT1/MATE1 or OCT2/MATE1: determinants of uptake and transcellular translocation of organic cations.
    König J; Zolk O; Singer K; Hoffmann C; Fromm MF
    Br J Pharmacol; 2011 Jun; 163(3):546-55. PubMed ID: 20883471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cisplatin and oxaliplatin, but not carboplatin and nedaplatin, are substrates for human organic cation transporters (SLC22A1-3 and multidrug and toxin extrusion family).
    Yonezawa A; Masuda S; Yokoo S; Katsura T; Inui K
    J Pharmacol Exp Ther; 2006 Nov; 319(2):879-86. PubMed ID: 16914559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Nonmetabolized β-Blocker Nadolol Is a Substrate of OCT1, OCT2, MATE1, MATE2-K, and P-Glycoprotein, but Not of OATP1B1 and OATP1B3.
    Misaka S; Knop J; Singer K; Hoier E; Keiser M; Müller F; Glaeser H; König J; Fromm MF
    Mol Pharm; 2016 Feb; 13(2):512-9. PubMed ID: 26702643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transport of asymmetric dimethylarginine (ADMA) by cationic amino acid transporter 2 (CAT2), organic cation transporter 2 (OCT2) and multidrug and toxin extrusion protein 1 (MATE1).
    Strobel J; Müller F; Zolk O; Endreß B; König J; Fromm MF; Maas R
    Amino Acids; 2013 Oct; 45(4):989-1002. PubMed ID: 23864433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of Renal Efflux Transporter MATE1 in Renal Excretion of Flecainide.
    Doki K; Apáti S; Sakata T; Homma M
    Biol Pharm Bull; 2019; 42(7):1226-1229. PubMed ID: 31257298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of human multidrug and toxin extrusion 1 in the drug interaction between cimetidine and metformin in renal epithelial cells.
    Tsuda M; Terada T; Ueba M; Sato T; Masuda S; Katsura T; Inui K
    J Pharmacol Exp Ther; 2009 Apr; 329(1):185-91. PubMed ID: 19164462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction and Transport of Methamphetamine and its Primary Metabolites by Organic Cation and Multidrug and Toxin Extrusion Transporters.
    Wagner DJ; Sager JE; Duan H; Isoherranen N; Wang J
    Drug Metab Dispos; 2017 Jul; 45(7):770-778. PubMed ID: 28428365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and pharmacological characterization of a specific agmatine transport system in human tumor cell lines.
    Molderings GJ; Bruss M; Bonisch H; Gothert M
    Ann N Y Acad Sci; 2003 Dec; 1009():75-81. PubMed ID: 15028572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interplay of the Organic Cation Transporters OCT1 and OCT2 with the Apically Localized Export Protein MATE1 for the Polarized Transport of Trospium.
    Deutsch B; Neumeister C; Schwantes U; Fromm MF; König J
    Mol Pharm; 2019 Feb; 16(2):510-517. PubMed ID: 30656943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.